Fintel reports that on April 25, 2025, HSBC downgraded their outlook for Align Technology (NasdaqGS:ALGN) from Buy to Hold.

Researchers have developed a method to gauge alignment between human goals and AI agents, addressing the 'alignment problem' where AI systems may not act according to human values. This is crucial as ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BofA analyst Michael Ryskin lowered the firm’s price target on Align Technology (ALGN) to $185 from $200 and keeps an Underperform rating on the shares.Heading into Q1 earnings, the firm trimmed ...

SAN JOSE, Calif. & TEMPE, Ariz.& PHILADELPHIA--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ...